Thoracoscopic talc poudrage versus povidone-iodine for pleurodesis of effusion due to metastatic breast cancer

T. A. Mohsen, A. A. Abou Zeid (Cairo, Egypt)

Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session: Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session type: Electronic Poster Session
Number: 4321
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. A. Mohsen, A. A. Abou Zeid (Cairo, Egypt). Thoracoscopic talc poudrage versus povidone-iodine for pleurodesis of effusion due to metastatic breast cancer. Eur Respir J 2006; 28: Suppl. 50, 4321

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of thoracoscopic talc poudrage pleurodesis and predictive factors for its success in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005

Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
Source: International Congress 2016 – Pleural diseases
Year: 2016


Thoracoscopic talc pleurodesis in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 172s
Year: 2005

Thoracoscopic talc pleurodesis in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005

Safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in malignant pleural effusion
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 509s
Year: 2003

Efficacy of talc pleurodesis in patients with malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Life expectancy of patients with malignant pleural effusion treated by video-assisted thoracoscopic talc pleurodesis
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004

Thoracoscopic pleurodesis for malignant pleural effusion
Source: ERS Skills Course 2015
Year: 2015

Thoracoscopic talc poudrage in pneumothorax
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015


Efficacy and safety of talc pleurodesis in patients with malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006

Thoracoscopic talc poudrage induces T-lymphopenia
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Videothoracoscopy is effective for the management of pneumothorax recurrences after talc pleurodesis
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003

The effectiveness of concomitant endobronchial treatment and video assisted thoracic surgery pleurodesis in lung cancer cases with pleural effusion
Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS)
Year: 2017

A spray catheter technique of lidocaine for controlling pain after talc poudrage in patients with malignant pleural effusion
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Therapeutic local procedures: pleurodesis
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=311
Year: 2002

Talc pleurodesis: talc slurry versus thoracoscopic talc poudrage
Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Year: 2008


VATS or simple talc poudrage under medical thoracoscopy for recurrent spontaneous pneumothorax
Source: Eur Respir J 2009; 33: 442-443
Year: 2009


Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Source: Eur Respir J 2007; 29: 757-760
Year: 2007



Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020